ICU MEDICAL INC (ICUI) Fundamental Analysis & Valuation

NASDAQ:ICUI • US44930G1076

133.34 USD
+1.34 (+1.02%)
At close: Mar 9, 2026
133.34 USD
0 (0%)
After Hours: 3/9/2026, 8:11:47 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ICUI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ICUI. ICUI was compared to 184 industry peers in the Health Care Equipment & Supplies industry. ICUI has an average financial health and profitability rating. ICUI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. ICUI Profitability Analysis

1.1 Basic Checks

  • In the past year ICUI was profitable.
  • ICUI had a positive operating cash flow in the past year.
  • In multiple years ICUI reported negative net income over the last 5 years.
  • ICUI had a positive operating cash flow in 4 of the past 5 years.
ICUI Yearly Net Income VS EBIT VS OCF VS FCFICUI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of ICUI (0.02%) is better than 71.20% of its industry peers.
  • ICUI has a better Return On Equity (0.03%) than 71.74% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.43%, ICUI is in the better half of the industry, outperforming 70.11% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ICUI is significantly below the industry average of 9.15%.
  • The 3 year average ROIC (1.99%) for ICUI is below the current ROIC(2.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROIC 2.43%
ROA(3y)-1.15%
ROA(5y)0.08%
ROE(3y)-2.45%
ROE(5y)-0.91%
ROIC(3y)1.99%
ROIC(5y)2.63%
ICUI Yearly ROA, ROE, ROICICUI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • The Profit Margin of ICUI (0.03%) is better than 71.74% of its industry peers.
  • In the last couple of years the Profit Margin of ICUI has declined.
  • ICUI has a Operating Margin of 4.90%. This is in the better half of the industry: ICUI outperforms 69.57% of its industry peers.
  • ICUI's Operating Margin has declined in the last couple of years.
  • ICUI has a Gross Margin of 36.84%. This is in the lower half of the industry: ICUI underperforms 71.74% of its industry peers.
  • In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
Industry RankSector Rank
OM 4.9%
PM (TTM) 0.03%
GM 36.84%
OM growth 3Y57.68%
OM growth 5Y-13.09%
PM growth 3YN/A
PM growth 5Y-65.63%
GM growth 3Y6.38%
GM growth 5Y0.29%
ICUI Yearly Profit, Operating, Gross MarginsICUI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ICUI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICUI is destroying value.
  • The number of shares outstanding for ICUI has been increased compared to 1 year ago.
  • The number of shares outstanding for ICUI has been increased compared to 5 years ago.
  • ICUI has a better debt/assets ratio than last year.
ICUI Yearly Shares OutstandingICUI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
ICUI Yearly Total Debt VS Total AssetsICUI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.10 indicates that ICUI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ICUI's Altman-Z score of 2.10 is fine compared to the rest of the industry. ICUI outperforms 61.96% of its industry peers.
  • The Debt to FCF ratio of ICUI is 15.58, which is on the high side as it means it would take ICUI, 15.58 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ICUI (15.58) is better than 71.20% of its industry peers.
  • A Debt/Equity ratio of 0.60 indicates that ICUI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ICUI (0.60) is worse than 61.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 15.58
Altman-Z 2.1
ROIC/WACC0.25
WACC9.65%
ICUI Yearly LT Debt VS Equity VS FCFICUI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.39 indicates that ICUI has no problem at all paying its short term obligations.
  • The Current ratio of ICUI (2.39) is comparable to the rest of the industry.
  • A Quick Ratio of 1.15 indicates that ICUI should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.15, ICUI is not doing good in the industry: 71.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.15
ICUI Yearly Current Assets VS Current LiabilitesICUI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ICUI Growth Analysis

3.1 Past

  • ICUI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.76%, which is quite impressive.
  • Measured over the past 5 years, ICUI shows a small growth in Earnings Per Share. The EPS has been growing by 1.71% on average per year.
  • Looking at the last year, ICUI shows a decrease in Revenue. The Revenue has decreased by -6.33% in the last year.
  • Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 11.91% on average per year.
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
Revenue 1Y (TTM)-6.33%
Revenue growth 3Y-0.72%
Revenue growth 5Y11.91%
Sales Q2Q%-13.78%

3.2 Future

  • Based on estimates for the next years, ICUI will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.23% on average per year.
  • ICUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.49% yearly.
EPS Next Y6.62%
EPS Next 2Y9.98%
EPS Next 3Y9.85%
EPS Next 5Y9.23%
Revenue Next Year-1.33%
Revenue Next 2Y1.52%
Revenue Next 3Y3.23%
Revenue Next 5Y4.49%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICUI Yearly Revenue VS EstimatesICUI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
ICUI Yearly EPS VS EstimatesICUI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. ICUI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.18, the valuation of ICUI can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 84.24% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.46, ICUI is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 16.12 indicates a correct valuation of ICUI.
  • Based on the Price/Forward Earnings ratio, ICUI is valued cheaper than 84.78% of the companies in the same industry.
  • ICUI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.65, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.18
Fwd PE 16.12
ICUI Price Earnings VS Forward Price EarningsICUI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 82.07% of the companies in the same industry are more expensive than ICUI, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICUI indicates a somewhat cheap valuation: ICUI is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 39.75
EV/EBITDA 13.68
ICUI Per share dataICUI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.6
PEG (5Y)10.06
EPS Next 2Y9.98%
EPS Next 3Y9.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICUI Dividend Analysis

5.1 Amount

  • ICUI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICUI Fundamentals: All Metrics, Ratios and Statistics

ICU MEDICAL INC

NASDAQ:ICUI (3/9/2026, 8:11:47 PM)

After market: 133.34 0 (0%)

133.34

+1.34 (+1.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners116.08%
Inst Owner Change-1.88%
Ins Owners0.96%
Ins Owner Change-2.94%
Market Cap3.29B
Revenue(TTM)2.23B
Net Income(TTM)732.00K
Analysts83.33
Price Target187.27 (40.45%)
Short Float %4.25%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.77%
Min EPS beat(2)10.68%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)29.63%
Min EPS beat(4)10.68%
Max EPS beat(4)38.85%
EPS beat(8)8
Avg EPS beat(8)31.35%
EPS beat(12)12
Avg EPS beat(12)27.15%
EPS beat(16)15
Avg EPS beat(16)20.28%
Revenue beat(2)1
Avg Revenue beat(2)0.72%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)2.43%
Revenue beat(4)2
Avg Revenue beat(4)0.69%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)0.8%
Revenue beat(12)6
Avg Revenue beat(12)-0.83%
Revenue beat(16)7
Avg Revenue beat(16)-0.86%
PT rev (1m)1.21%
PT rev (3m)1.21%
EPS NQ rev (1m)-1.51%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)0.87%
EPS NY rev (3m)0.87%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)1%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 17.18
Fwd PE 16.12
P/S 1.48
P/FCF 39.75
P/OCF 18.31
P/B 1.55
P/tB N/A
EV/EBITDA 13.68
EPS(TTM)7.76
EY5.82%
EPS(NY)8.27
Fwd EY6.2%
FCF(TTM)3.35
FCFY2.52%
OCF(TTM)7.28
OCFY5.46%
SpS90.37
BVpS86.02
TBVpS-0.38
PEG (NY)2.6
PEG (5Y)10.06
Graham Number122.55
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROCE 3.08%
ROIC 2.43%
ROICexc 2.66%
ROICexgc 7.78%
OM 4.9%
PM (TTM) 0.03%
GM 36.84%
FCFM 3.71%
ROA(3y)-1.15%
ROA(5y)0.08%
ROE(3y)-2.45%
ROE(5y)-0.91%
ROIC(3y)1.99%
ROIC(5y)2.63%
ROICexc(3y)2.16%
ROICexc(5y)3.42%
ROICexgc(3y)6.21%
ROICexgc(5y)6.59%
ROCE(3y)2.51%
ROCE(5y)3.33%
ROICexgc growth 3Y68.14%
ROICexgc growth 5Y-6.18%
ROICexc growth 3Y65.14%
ROICexc growth 5Y-20.85%
OM growth 3Y57.68%
OM growth 5Y-13.09%
PM growth 3YN/A
PM growth 5Y-65.63%
GM growth 3Y6.38%
GM growth 5Y0.29%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 15.58
Debt/EBITDA 4.09
Cap/Depr 48.33%
Cap/Sales 4.35%
Interest Coverage 1.31
Cash Conversion 58%
Profit Quality 11315.8%
Current Ratio 2.39
Quick Ratio 1.15
Altman-Z 2.1
F-Score6
WACC9.65%
ROIC/WACC0.25
Cap/Depr(3y)43.46%
Cap/Depr(5y)52.62%
Cap/Sales(3y)4.09%
Cap/Sales(5y)4.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
EPS Next Y6.62%
EPS Next 2Y9.98%
EPS Next 3Y9.85%
EPS Next 5Y9.23%
Revenue 1Y (TTM)-6.33%
Revenue growth 3Y-0.72%
Revenue growth 5Y11.91%
Sales Q2Q%-13.78%
Revenue Next Year-1.33%
Revenue Next 2Y1.52%
Revenue Next 3Y3.23%
Revenue Next 5Y4.49%
EBIT growth 1Y6.35%
EBIT growth 3Y56.54%
EBIT growth 5Y-2.74%
EBIT Next Year28.75%
EBIT Next 3Y15.51%
EBIT Next 5Y12.24%
FCF growth 1Y-27.23%
FCF growth 3YN/A
FCF growth 5Y-7.51%
OCF growth 1Y-11.85%
OCF growth 3YN/A
OCF growth 5Y-4.19%

ICU MEDICAL INC / ICUI FAQ

What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ICUI.


Can you provide the valuation status for ICU MEDICAL INC?

ChartMill assigns a valuation rating of 5 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.


What is the profitability of ICUI stock?

ICU MEDICAL INC (ICUI) has a profitability rating of 5 / 10.


Can you provide the financial health for ICUI stock?

The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.


What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?

The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 6.62% in the next year.